Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
07/2012
07/18/2012CN102584512A Method for synthesizing benzofuran derivatives in one pot process
07/18/2012CN101792434B Preparation method of tetra-acylated puerarin
07/18/2012CN101522629B 2-aminocarbonyl-pyridine derivatives
07/17/2012CA2635479C A process for preparation of racemic nebivolol
07/17/2012CA2334342C Epothilone derivatives and their synthesis and use
07/12/2012US20120178949 Preparation of an active intermediate
07/12/2012US20120178764 Novel Compounds
07/12/2012US20120175600 Aromatic amine derivative, and organic electroluminescent element
07/11/2012EP2473495A1 Pharmaceutical compounds
07/11/2012EP2473487A1 Quinazolines as potassium ion channel inhibitors
07/11/2012CN102574833A Amides and thioamides as pesticides
07/11/2012CN102574817A Aminoquinazoline compounds for combating invertebrate pests
07/11/2012CN102558164A Benzopyrone estrogen receptor (ER) modulator
07/11/2012CN102558162A Processing and extraction method for silybin with low soluble residues and high content
07/11/2012CN102558075A Substituted piperazines as CB1 antagonists
07/11/2012CN102558062A Method for synthesizing imidazole-amino acid derivative and related compound
07/10/2012US8217187 Process to extract quassinoids
07/05/2012WO2012092484A2 Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
07/05/2012WO2012090220A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
07/05/2012WO2012089349A2 Novel polyketide compounds and methods of making same
07/05/2012US20120172606 Sulfonium compound, photo-acid generator, and method for manufacturing the same
07/05/2012US20120172583 Oligonucleotides and Analogs Labeled with Energy Transfer Dyes
07/05/2012US20120172351 Novel fused cyclic compound and use thereof
07/05/2012US20120172337 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
07/05/2012US20120171601 Furan derivative and electrophotographic photoconductor
07/05/2012US20120170098 Chromene compound
07/05/2012CA2820854A1 Heterocyclic compounds suitable for the treatment of dyslipidemia
07/04/2012EP2470520A1 Chromone derivatives, a process for their preparation and their therapeutic applications
07/04/2012CN102548557A Compounds for the reduction of beta-amyloid production
07/04/2012CN102532113A Aryl urea derivative
07/04/2012CN102532112A Dynamic rotating vacuum drying method for removing solvent residual on the surface of silymarin
07/04/2012CN102532111A Method for extracting puerarin from traditional Chinese medicine kudzu
07/04/2012CN102532082A 2,2-dimethyl benzopyran compound and preparation method and application thereof
07/04/2012CN102532070A Natural products as retinoic acid receptor (RARs) agonists and application thereof
07/04/2012CN102531815A Method for asymmetric catalyzing epoxidation reaction of alpha, beta-unsaturated carbonyl compounds
07/04/2012CN101973984B Method for extracting general flavones from bamboo leaves
07/04/2012CN101613347B Amine compound and medical application thereof
07/04/2012CN101248064B Nitrocatechol derivatives as COMT inhibitors
07/03/2012US8211338 Photochromic compounds
07/03/2012CA2564355C Protein kinase modulators and method of use
06/2012
06/28/2012WO2012087007A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/28/2012US20120165528 Chiral binaphthyl compounds
06/28/2012US20120161119 Aromatic amine derivative and organic electroluminescence device
06/27/2012EP2467364A2 Nitrogen-containing compounds and pharmaceutical compositions thereof for the treatment of atrial fibrillation
06/27/2012EP1719762B1 Novel pyridine derivative and pyrimidine derivative (1)
06/27/2012CN102516210A Preparation method of 2,3-dicyanofuran compound
06/27/2012CN102516161A Pyridine and pyrimidine derivatives as mglur2 antagonists
06/27/2012CN101506162B Substituted isoindoles as bace inhibitors and their use
06/27/2012CN101486699B Prostaglandin synthesis
06/27/2012CN101454285B Oxadiazole derivatives as comt inhibitors
06/26/2012US8207358 Methods for the preparation of taxanes using chiral auxiliaries
06/26/2012US8206747 Drug loaded polymeric nanoparticles and methods of making and using same
06/21/2012WO2012082633A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012WO2012082566A1 Sulfur derivatives as chemokine receptor modulators
06/21/2012WO2012082560A1 Methods of making fused ring compounds
06/21/2012WO2012082513A1 Lactone compounds and materials made therefrom
06/21/2012WO2012082506A1 Photochromic compounds and compositions
06/21/2012WO2012080476A1 Fused dihydropyrans as gpr119 modulators for the treatment of diabetes, obesity and related diseases
06/21/2012WO2012079203A1 Puerarin hydrates, preparation methods and uses thereof
06/21/2012CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012CA2822039A1 Sulfur derivatives as chemokine receptor modulators
06/21/2012CA2820594A1 Lactone compounds and materials made therefrom
06/21/2012CA2820033A1 Photochromic compounds and compositions
06/20/2012EP2464632A1 Pyrimidone derivatives used as tau protein kinase 1 inhibitors
06/20/2012CN102510867A Glycoside derivative and uses thereof
06/19/2012US8202870 Substituted oxindole derivatives, medicaments containing the latter and use thereof
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/19/2012US8202855 Substituted beta-lactams
06/19/2012CA2523439C Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
06/14/2012WO2012078545A1 Benzofurane derivatives for the treatment of hepatitits c
06/14/2012US20120149807 Diepoxy compound, process for producing same, and composition containing the diepoxy compound
06/14/2012US20120149019 Use of a bis-maleic anhydride cross-linking agent for fixation of a cell or tissue sample
06/14/2012US20120145958 Tetrahydropyran compound, liquid crystal composition and liquid crystal display device
06/13/2012EP2462136A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors
06/13/2012EP2462135A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors
06/13/2012EP1704145B1 Selective kinase inhibitors
06/13/2012CN102498091A Glycine compound
06/13/2012CN101346367B Adducts of levulinic derivatives with epoxidized fatty acid esters and uses thereof
06/07/2012WO2012074675A2 Toughening cross-linked thermosets
06/07/2012WO2012072691A1 Indanyloxydihydrobenzofuranylacetic acids
06/07/2012WO2012033631A3 Roseobacticides and uses thereof
06/06/2012EP2460793A1 Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles And Their Use as Tubulin Polymerisation Inhibitors
06/06/2012EP2459529A1 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
06/06/2012EP2459524A2 Novel compounds as modulators of glucocorticoid receptors
06/06/2012EP2459197A1 Compounds for the reduction of -amyloid production
06/05/2012US8193354 Process for preparation of Gemcitabine hydrochloride
06/05/2012CA2482041C 4-chromanone derivatives for treating cellular proliferative diseases and disorders
05/2012
05/31/2012WO2012070437A1 Method for producing optically active fluorine-containing oxeten
05/31/2012WO2012070015A1 Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
05/31/2012WO2012069601A1 Substituted quinazolines as fungicides
05/31/2012US20120136148 Photochromic Compounds Having At Least Two Photochromic Moieties
05/30/2012EP2456772A2 Compounds, compositions and methods for protecting brain health in neurodegenerative disorders
05/30/2012EP2456768A1 Process for preparing nebivolol
05/30/2012EP2456310A1 Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators
05/30/2012CN102482257A Apoptosis signal-regulating kinase inhibitors
05/30/2012CN102482251A 色酮衍生物、其制备方法及其治疗应用 Chromone derivatives, their preparation and their therapeutic application
05/30/2012CN102482249A Tofa analogs useful in treating dermatological disorders or conditions
05/30/2012CN102482244A Covalent inhibition of bacterial quorum sensing
05/30/2012CN102482234A Nitrogen-containing compound and pharmaceutical composition
05/30/2012CN101679392B Quinolone compound and pharmaceutical composition
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 120